Research Development - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Portage Biotech Inc
Research & Development Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Research & Development
-$10.2m
CAGR 3-Years
-8%
CAGR 5-Years
-55%
CAGR 10-Years
-19%
Theratechnologies Inc
TSX:TH
Research & Development
-$19.1m
CAGR 3-Years
5%
CAGR 5-Years
-16%
CAGR 10-Years
-10%
Repare Therapeutics Inc
NASDAQ:RPTX
Research & Development
-$131.8m
CAGR 3-Years
-50%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Research & Development
-$33.5m
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
-21%
Covalon Technologies Ltd
XTSX:COV
Research & Development
-CA$1.5m
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-13%
Spectral Medical Inc
TSX:EDT
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Portage Biotech Inc's Research & Development?
Research & Development
-10.2m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Research & Development amounts to -10.2m USD.

What is Portage Biotech Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-19%

Over the last year, the Research & Development growth was -2%. The average annual Research & Development growth rates for Portage Biotech Inc have been -8% over the past three years , -55% over the past five years , and -19% over the past ten years .

Back to Top